Literature DB >> 27857504

Impaired hematopoietic progenitor cells in trauma hemorrhagic shock.

Manoj Kumar1, Sanjeev Bhoi1.   

Abstract

Hemorrhagic shock (HS) is the major cause of death during trauma. Mortality due to HS is about 50%. Dysfunction of hematopoietic progenitor cells (HPCs) has been observed during severe trauma and HS. HS induces the elevation of cytokines, granulocyte-colony stimulating factor (G-CSF), peripheral blood HPCs, and circulating catecholamines, and decreases the expression of erythropoietin receptor connected with suppression of HPCs. Impaired HPCs may lead to persistent anemia and risk of susceptibility to infection, sepsis, and MOF. There is a need to reactivate impaired HPCs during trauma hemorrhagic shock.

Entities:  

Keywords:  Cytokine; Erythropoietin; Granulocyte-colony stimulating factor; Hematopoietic progenitor cells; Trauma hemorrhagic shock

Year:  2016        PMID: 27857504      PMCID: PMC5106469          DOI: 10.1016/j.jcot.2016.05.013

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  29 in total

Review 1.  Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor.

Authors:  John Thomas; Fulu Liu; Daniel C Link
Journal:  Curr Opin Hematol       Date:  2002-05       Impact factor: 3.284

2.  Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death.

Authors:  E Morishita; S Masuda; M Nagao; Y Yasuda; R Sasaki
Journal:  Neuroscience       Date:  1997-01       Impact factor: 3.590

3.  Daily propranolol prevents prolonged mobilization of hematopoietic progenitor cells in a rat model of lung contusion, hemorrhagic shock, and chronic stress.

Authors:  Letitia E Bible; Latha V Pasupuleti; Amy V Gore; Ziad C Sifri; Kolenkode B Kannan; Alicia M Mohr
Journal:  Surgery       Date:  2015-07-21       Impact factor: 3.982

Review 4.  Erythropoiesis in multiply injured patients.

Authors:  Yohan Robinson; Arwed Hostmann; Alexander Matenov; Wolfgang Ertel; Andreas Oberholzer
Journal:  J Trauma       Date:  2006-11

5.  Bone marrow failure following severe injury in humans.

Authors:  David H Livingston; Devashish Anjaria; Jonathan Wu; Carl J Hauser; Victor Chang; Edwin A Deitch; Pranela Rameshwar
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

6.  TNF-independent development of transient anemia of chronic disease in a mouse model of protracted septic peritonitis.

Authors:  Thomas Schubert; Bernd Echtenacher; Ferdinand Hofstädter; Daniela N Männel
Journal:  Lab Invest       Date:  2003-12       Impact factor: 5.662

7.  Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis.

Authors:  H Tanaka; K Ishikawa; M Nishino; T Shimazu; T Yoshioka
Journal:  J Trauma       Date:  1996-05

8.  Hematopoietic stem cells: Can it be a therapeutic option for the hematopoietic failure in patients with trauma-hemorrhagic shock?

Authors:  Manoj Kumar; Sanjeev Bhoi; Sagar Galwankar
Journal:  J Emerg Trauma Shock       Date:  2016 Apr-Jun

9.  Evaluation of circulating haematopoietic progenitor cells in patients with Trauma Haemorrhagic shock and its correlation with outcomes.

Authors:  Manoj Kumar; Sanjeev Bhoi; Arulselvi Subramanian; Vineet Kumar Kamal; Sujata Mohanty; D N Rao; Sagar Galwankar
Journal:  Int J Crit Illn Inj Sci       Date:  2016 Apr-Jun

10.  The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the Global Burden of Disease study 2013.

Authors:  Juanita A Haagsma; Nicholas Graetz; Ian Bolliger; Mohsen Naghavi; Hideki Higashi; Erin C Mullany; Semaw Ferede Abera; Jerry Puthenpurakal Abraham; Koranteng Adofo; Ubai Alsharif; Emmanuel A Ameh; Walid Ammar; Carl Abelardo T Antonio; Lope H Barrero; Tolesa Bekele; Dipan Bose; Alexandra Brazinova; Ferrán Catalá-López; Lalit Dandona; Rakhi Dandona; Paul I Dargan; Diego De Leo; Louisa Degenhardt; Sarah Derrett; Samath D Dharmaratne; Tim R Driscoll; Leilei Duan; Sergey Petrovich Ermakov; Farshad Farzadfar; Valery L Feigin; Richard C Franklin; Belinda Gabbe; Richard A Gosselin; Nima Hafezi-Nejad; Randah Ribhi Hamadeh; Martha Hijar; Guoqing Hu; Sudha P Jayaraman; Guohong Jiang; Yousef Saleh Khader; Ejaz Ahmad Khan; Sanjay Krishnaswami; Chanda Kulkarni; Fiona E Lecky; Ricky Leung; Raimundas Lunevicius; Ronan Anthony Lyons; Marek Majdan; Amanda J Mason-Jones; Richard Matzopoulos; Peter A Meaney; Wubegzier Mekonnen; Ted R Miller; Charles N Mock; Rosana E Norman; Ricardo Orozco; Suzanne Polinder; Farshad Pourmalek; Vafa Rahimi-Movaghar; Amany Refaat; David Rojas-Rueda; Nobhojit Roy; David C Schwebel; Amira Shaheen; Saeid Shahraz; Vegard Skirbekk; Kjetil Søreide; Sergey Soshnikov; Dan J Stein; Bryan L Sykes; Karen M Tabb; Awoke Misganaw Temesgen; Eric Yeboah Tenkorang; Alice M Theadom; Bach Xuan Tran; Tommi J Vasankari; Monica S Vavilala; Vasiliy Victorovich Vlassov; Solomon Meseret Woldeyohannes; Paul Yip; Naohiro Yonemoto; Mustafa Z Younis; Chuanhua Yu; Christopher J L Murray; Theo Vos
Journal:  Inj Prev       Date:  2015-12-03       Impact factor: 2.399

View more
  3 in total

Review 1.  Human-induced pluripotent stem cells derived hematopoietic progenitor cells for treatment of hematopoietic failure among trauma hemorrhagic shock patients.

Authors:  Manoj Kumar; Sanjeev Bhoi; Keshava Sharma
Journal:  J Clin Orthop Trauma       Date:  2018-04-22

2.  Flow Cytometric Analysis of Hematopoietic Populations in Rat Bone Marrow. Impact of Trauma and Hemorrhagic Shock.

Authors:  Wendy R Francis; Rachel E Ireland; Abigail M Spear; Dominic Jenner; Sarah A Watts; Emrys Kirkman; Ian Pallister
Journal:  Cytometry A       Date:  2019-10-09       Impact factor: 4.355

3.  Profiling the Expression of Circulating Acute-Phase Proteins, Cytokines, and Checkpoint Proteins in Patients with Severe Trauma: A Pilot Study.

Authors:  Shao-Chun Wu; Cheng-Shyuan Rau; Pao-Jen Kuo; Fu-Yuan Shih; Hui-Ping Lin; Yi-Chan Wu; Ting-Min Hsieh; Hang-Tsung Liu; Ching-Hua Hsieh
Journal:  J Inflamm Res       Date:  2021-08-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.